Aap Implantate AG
Aap Implantate AG is a medical equipment and supplies company that provides orthopedic and trauma-related implants and solutions to healthcare providers.
Business. Aap Implantate AG (AAQ1K.DE) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue through the sale of products, though specific operating segments and geographic breakdowns are not disclosed. The company is primarily listed on the Xetra exchange.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Aap Implantate AG (AAQ1K.DE) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue through the sale of products, though specific operating segments and geographic breakdowns are not disclosed. The company is primarily listed on the Xetra exchange.
Aap Implantate AG has 13,907,656 basic and diluted shares outstanding, with no dilution risk currently identified. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
The company reported a revenue of €2,957,000 in the latest period, but no profitability or return metrics are available for comparison with industry benchmarks. Analyst estimates indicate a recent actual revenue of €11,516,000 and an EPS of -€0.39, suggesting a loss-making position.
Segment and geographic exposure data are not disclosed in the available information, making it difficult to assess revenue concentration or geographic diversification.
Growth trajectory is unclear due to the lack of historical revenue data and forward-looking guidance. Analyst estimates do not provide a clear direction for the current or next fiscal year.
The company faces a key risk flag related to liquidity, as no balance-sheet inputs are available to assess its short-term financial health. No dilution risk is currently identified, but the absence of detailed capital structure data limits further analysis.
Recent events and filings do not provide additional insights into the company's operations or strategic direction. No recent transcripts or filings are available to inform the narrative.
- Aap Implantate AG operates in the medical equipment and supplies industry with a focus on orthopedic and trauma-related implants.
- The company has 13,907,656 basic and diluted shares outstanding, with no dilution risk currently identified.
- Revenue of €2,957,000 was reported in the latest period, but profitability metrics are not available for comparison with industry benchmarks.
- Analyst estimates indicate a recent actual revenue of €11,516,000 and an EPS of -€0.39, suggesting a loss-making position.
- Liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Revenue €3.1M, +4,3% YoY; Operating income €3.1M.
- ▍Revenue €3.1M, +4,3% YoY
- ▍Operating income €3.1M
- ▍Net margin 100.0%
Revenue €3.0M.
- ▍Revenue €3.0M
Revenue €12.4M, +2,0% YoY.
- ▍Revenue €12.4M, +2,0% YoY
Revenue €12.2M, +6,3% YoY; Operating income +63,4% YoY.
- ▍Revenue €12.2M, +6,3% YoY
- ▍Operating income +63,4% YoY
- ▍Net income +54,4% YoY
- ▍Free cash flow +51,0% YoY
- ▍Net margin -29.7%
Revenue €11.5M, −0,3% YoY; Operating income −118,8% YoY.
- ▍Revenue €11.5M, −0,3% YoY
- ▍Operating income −118,8% YoY
- ▍Net income −210,6% YoY
- ▍Free cash flow −190,8% YoY
- ▍Net margin -69.4%
Revenue €11.5M, −5,3% YoY; Operating income −29,8% YoY.
- ▍Revenue €11.5M, −5,3% YoY
- ▍Operating income −29,8% YoY
- ▍Net income −1,7% YoY
- ▍Free cash flow −14,6% YoY
- ▍Net margin -22.3%
Revenue €12.2M; Operating income -€2.6M.
- ▍Revenue €12.2M
- ▍Operating income -€2.6M
- ▍Net margin -20.7%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Aap Implantate AG Market data — financials · 2026-05-27
- Aap Implantate AG Market data — analyst estimates · 2026-05-27